Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Cellectar Biosciences, Inc.
GlaxoSmithKline
Valo Therapeutics Oy
Emerald Clinical Inc.